WeSearch
Hub / Tags / Abbvie
TAG · #ABBVIE

Abbvie coverage.

Every story in the WeSearch catalog tagged with #abbvie, chronological, with view counts. Subscribe to the per-tag RSS feed to follow this topic in your reader of choice.

12 stories tagged with #abbvie, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.

⌘ RSS feed for this tag →   or   search "Abbvie"

RELATED TAGS
#investing3#inc3#abbvie-inc2#rheumatoid-arthritis1#clinical-trial1#upadacitinib1#adalimumab1#treatment1#eduardo-mysler1#organizaci-n-medica-de-investigaci-n1#buenos-aires1#annals-of-the-rheumatic-diseases1
YAHOO FINANCE

AbbVie Delivers 400% Returns Beating The S&P 500 by 139%

10 views ·
YAHOO FINANCE

This Is What a $1 Million Dividend Portfolio Pays After Taxes

At the 24% federal bracket, a $1 million dividend portfolio generating roughly $45,000 in annual income can hand the IRS between $6,750 and $10,800 every year, depending on how muc…

10 views ·
#finance#investing#taxes
SEEKING ALPHA

AbbVie Inc. (ABBV) Presents at EU Clinical Trial Regulation: Latest Developments and Upcoming Opportunities Transcript

AbbVie Inc. (ABBV) EU Clinical Trial Regulation: Latest Developments and Upcoming Opportunities May 28, 2026 10:00 AM EDTCompany ParticipantsSonia...…

10 views ·
#healthcare#clinical trials#regulation
INVESTING.COM — NEWS

AbbVie receives FDA approval for BPDCN blood cancer treatment

15 views ·
YAHOO FINANCE

Piper Sandler Raises Price Target on AbbVie (ABBV) Amid Strong IBD Pipeline Progress

11 views ·
SEEKING ALPHA

My Dividend Stock Portfolio: New April Dividend Record - 100 Holdings With 5 Buys

April net investment activity reached a multi-year low. Read what prompted a cautious approach and check out the dividend portfolio here.…

19 views ·
#dividends#investing#stocks
YAHOO FINANCE

Two Paths to Growth: Johnson & Johnson vs AbbVie

21 views ·
YAHOO FINANCE

What's the Better Dividend Stock Today: AbbVie or Pfizer?

20 views ·
SEEKING ALPHA

Apogee Therapeutics: Targeting Atopic Dermatitis

Apogee Therapeutics, Inc. is rated a Hold, driven by promising data for the lead asset zumilokibart in atopic dermatitis. Read more on APGE stock here.…

13 views ·
#healthcare#biopharmaceuticals#investing
YAHOO FINANCE

AbbVie (ABBV) Price Target Lowered to $235 at Evercore ISI

16 views ·
MEDSCAPE

Migraine Med Shows Weight-Loss Benefit

New data show early and sustained weight loss with atogepant, raising the possibility of metabolic benefits beyond migraine prevention.…

12 views ·
#health#medicine#research
MEDSCAPE

Upadacitinib After TNF Inhibitor Failure Improves RA Control

In patients with active RA, switching to upadacitinib after failure of a single TNF inhibitor is more effective in reducing disease activity at 12 weeks than using a second TNF inh…

13 views ·
#rheumatoid arthritis#clinical trial#upadacitinib